Clinical Trials

NCT06571734 | RECRUITING | PHASE2
73 participants

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2024-09-19
Completion:
2028-07-01
Conditions
  • Metastatic Leiomyosarcoma
  • Unresectable Leiomyosarcoma
  • Bone Sarcoma
  • Translocation-associated Soft Tissue Sarcoma
  • Synovial Sarcomas
  • Osteosarcoma Metastatic
  • Ewing Sarcoma
  • Ewing Sarcoma Metastatic
  • Sarcoma Metastatic
  • Sarcoma of Bone
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT06381154 | ACTIVE_NOT_RECRUITING | PHASE2
24 participants

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2024-12-06
Completion:
2028-03-31
Conditions
  • Locally Advanced Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Adenocarcinoma
Interventions
  • OTHER
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06310291 | RECRUITING | EARLY_PHASE1
45 participants

VTP-1000 in Adults With Celiac Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2024-08-01
Completion:
2026-11-30
Conditions
  • Celiac Disease
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06306157 | ENROLLING_BY_INVITATION | PHASE4
40 participants

Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2024-01-02
Completion:
2026-08-31
Conditions
  • Complex Regional Pain Syndrome
  • Chronic Pain
  • Causalgia
  • Complex Regional Pain Syndrome Type I
  • Complex Regional Pain Syndrome Type II
Interventions
  • DRUG
No Results Yet
NCT06257264 | ACTIVE_NOT_RECRUITING | PHASE1
103 participants

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2024-03-11
Completion:
2026-08-31
Conditions
  • Breast Cancer
  • Small Cell Lung Cancer
  • Ovarian Cancer
  • Gastric Cancer
  • Hormone-receptor-positive Breast Cancer
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Advanced Solid Tumor
  • Endometrial Cancer
  • Prostate Cancer
  • TNBC - Triple-Negative Breast Cancer
  • GastroEsophageal Cancer
  • Bladder Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page